Orally active purine-based inhibitors of heat shock protein 90

Details for Australian Patent Application No. 2006331917 (hide)

Owner Conforma Therapeutics Corporation

Inventors Hong, Kevin D.; Boehm, Marcus F.; Biamonte, Marco; Zhang, Lin; Shi, Jiandong; Fan, Junhua; Kasibhatla, Srinivas R.

Agent Spruson & Ferguson

Pub. Number AU-A-2006331917

PCT Pub. Number WO2007/075572

Priority 60/753,636 22.12.05 US; 60/753,698 22.12.05 US; 60/753,448 22.12.05 US

Filing date 18 December 2006

Wipo publication date 5 July 2007

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 473/12 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075572 Priority application(s): WO2007/075572

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331925-Recovery of residual plant components after distillation of essential oils

2006331912-Triazolopyridazines as tyrosine kinase modulators